Affiliation:
1. Northwestern University
2. Imperial College London
3. Sanford Burnham Prebys Medical Discovery Institute
Abstract
Abstract
SARS-CoV-2 initiates infection in the conducting airways, which rely on mucocilliary clearance (MCC) to minimize pathogen penetration. However, it is unclear how MCC impacts SARS-CoV-2 spread after infection is established. To understand viral spread at this site, we performed live imaging of SARS-CoV-2 infected differentiated primary human bronchial epithelium cultures for up to 9 days. Fluorescent markers for cilia and mucus allowed longitudinal monitoring of MCC, ciliary motion, and infection. The number of infected cells peaked at 4 days post-infection in characteristic foci that followed mucus movement. Inhibition of MCC using physical and genetic perturbations limited foci. Later in infection, MCC was diminished despite relatively subtle ciliary function defects. Resumption of MCC and infection spread after mucus removal suggests that mucus secretion mediates this effect. We show that MCC facilitates SARS-CoV-2 spread early in infection while later decreases in MCC inhibit spread, suggesting a complex interplay between SARS-CoV-2 and MCC.
Publisher
Research Square Platform LLC
Reference50 articles.
1. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract;Hou YJ;Cell,2020
2. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults;Killingley B;Nat. Med.,2022
3. Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study;Zhou J;Lancet Microbe,2023
4. Mucus clearance as a primary innate defense mechanism for mammalian airways;Knowles MR;J Clin Invest,2002
5. Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology;Zhang L;J Virol,2002